VentriPoint Diagnostics Ltd. VPTDF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -71.63% | -- | 60.04% | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -71.63% | -- | 60.04% | -100.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -71.63% | -- | 60.04% | -100.00% |
| SG&A Expenses | -61.32% | -44.94% | -23.58% | -34.72% | -3.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -56.01% | -40.68% | -29.05% | -40.97% | -18.25% |
| Operating Income | 57.64% | 38.07% | 29.46% | 46.42% | 16.44% |
| Income Before Tax | 48.37% | 26.57% | 77.87% | 40.48% | 10.21% |
| Income Tax Expenses | -- | -- | 37.25% | -- | -- |
| Earnings from Continuing Operations | 48.37% | 26.57% | 81.07% | 40.48% | 10.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 48.37% | 26.57% | 81.07% | 40.48% | 10.21% |
| EBIT | 57.64% | 38.07% | 29.46% | 46.42% | 16.44% |
| EBITDA | -- | -- | 29.50% | 46.46% | 16.44% |
| EPS Basic | 55.17% | 36.59% | 80.85% | 43.10% | 12.12% |
| Normalized Basic EPS | 58.33% | 38.46% | 21.88% | 41.67% | 12.20% |
| EPS Diluted | 55.17% | 36.59% | 80.85% | 43.10% | 12.12% |
| Normalized Diluted EPS | 58.33% | 38.46% | 21.88% | 41.67% | 12.20% |
| Average Basic Shares Outstanding | 16.91% | 14.86% | 4.16% | 6.22% | 1.86% |
| Average Diluted Shares Outstanding | 16.91% | 14.86% | 4.16% | 6.22% | 1.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |